[ad_1]
Tactile Systems Technology (NASDAQ:TCMD – Get Rating) and NuVasive (NASDAQ:NUVA – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.
Earnings and Valuation
This table compares Tactile Systems Technology and NuVasive’s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tactile Systems Technology | $208.06 million | 1.52 | -$11.81 million | ($1.26) | -12.61 |
| NuVasive | $1.14 billion | 2.57 | -$64.09 million | ($1.25) | -45.06 |
Tactile Systems Technology has higher earnings, but lower revenue than NuVasive. NuVasive is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Tactile Systems Technology has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, NuVasive has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations and price targets for Tactile Systems Technology and NuVasive, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tactile Systems Technology | 0 | 0 | 3 | 0 | 3.00 |
| NuVasive | 1 | 4 | 7 | 0 | 2.50 |
Tactile Systems Technology currently has a consensus target price of $34.00, suggesting a potential upside of 113.97%. NuVasive has a consensus target price of $65.40, suggesting a potential upside of 16.12%. Given Tactile Systems Technology’s stronger consensus rating and higher possible upside, research analysts clearly believe Tactile Systems Technology is more favorable than NuVasive.
Profitability
This table compares Tactile Systems Technology and NuVasive’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tactile Systems Technology | -5.68% | -7.31% | -4.45% |
| NuVasive | -5.63% | 10.65% | 4.08% |
Insider and Institutional Ownership
92.6% of Tactile Systems Technology shares are owned by institutional investors. 3.5% of Tactile Systems Technology shares are owned by company insiders. Comparatively, 0.5% of NuVasive shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
About Tactile Systems Technology (Get Rating)
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
About NuVasive (Get Rating)
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Receive News & Ratings for Tactile Systems Technology Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Tactile Systems Technology and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link